07:41 AM EDT, 10/11/2024 (MT Newswires) -- Sagimet Biosciences ( SGMT ) said Friday that its experimental drug, denifanstat, used to treat certain metabolic-dysfunction-associated steatohepatitis patients, met its primary and secondary endpoints in a phase 2b study. The study showed that patients treated with the denifanstat showed statistically significant and clinically meaningful improvements in disease activity, MASH resolution, and fibrosis...

Oct 11 (Reuters) - Vecima Networks Inc ( VNWTF ): * VECIMA ACQUIRES FALCON V SYSTEMS, PROVIDER OF INNOVATIVE SOFTWARE ORCHESTRATION PLATFORM FOR CABLE, FIBER, AND MOBILE ACCESS NETWORKS * VECIMA NETWORKS ( VNWTF ): CHARTER COMMUNICATIONS WILL BE INITIAL CUSTOMER, SIGNING MULTI-YEAR DEAL TO DEPLOY BOTH PRINCIPAL CORE & TEST SUITE Source text for Eikon: Further company coverage: ...

07:33 AM EDT, 10/11/2024 (MT Newswires) -- CAMP4 Therapeutics said late Thursday it priced its initial public offering of about 6.8 million common shares at $11 per share for expected gross proceeds of about $75 million. Underwriters have been granted a 30-day option to buy up to about 1 million additional shares. Shares of the biotechnology company are expected to...

07:44 AM EDT, 10/11/2024 (MT Newswires) -- AGBA (AGBA) and Triller said Friday they have finalized all necessary steps for their upcoming merger, expected to be completed around Oct. 14, pending final Nasdaq approval. As part of the merger, AGBA will undergo a reverse stock split at a 4-to-1 ratio to comply with Nasdaq requirements. The reverse split will be...